Similar Papers

Paper Title
Journal
Date
Author
Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience.
Holger Gerullis ... Thorsten Holger Ecke
Therapeutic Advances in Urology | VOL. 9
Holger Gerullis, et. al.Holger Gerullis ... Thorsten Holger Ecke
21 Nov 2016
Advanced Bladder Cancer with Multiple Pulmonary Metastases Treated with Paclitaxel/Ifosfamide/Nedaplatin Therapy : Two Case Reports
Toshihide Hosomi ... Yasumasa Shichiri
Hinyokika kiyo. Acta urologica Japonica | VOL. 69
Toshihide Hosomi, et. al.Toshihide Hosomi ... Yasumasa Shichiri
01 Jul 2023
Phase II trial of cisplatin, 5-fluorouracil, and interferon-α-2B as first line treatment of advanced urothelial cancer
Shouki Bazarbashi ... Kamal Hanash
Urologic Oncology: Seminars and Original Investigations | VOL. 21
Shouki Bazarbashi, et. al.Shouki Bazarbashi ... Kamal Hanash
01 May 2003
The first Slovak experience with second-line vinflunine in advanced urothelial carcinomas.
Patrik Palacka ... Michal Chovanec
Klinicka onkologie | VOL. 27
Patrik Palacka, et. al.Patrik Palacka ... Michal Chovanec
15 Dec 2014
View more papers

More From: Future oncology (London, England)

Paper Title
Journal
Date
Author
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304).
Ciara Conduit ...
Future oncology (London, England) | VOL. -
Ciara Conduit, et. al.Ciara Conduit ...
17 Jan 2025
Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer.
Ritu Salani ... Floor J Backes
Future oncology (London, England) | VOL. -
Ritu Salani, et. al.Ritu Salani ... Floor J Backes
17 Jan 2025
Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumors.
Kevin Harrington ... Patricia Lorusso
Future oncology (London, England) | VOL. -
Kevin Harrington, et. al.Kevin Harrington ... Patricia Lorusso
16 Jan 2025
Prevalence of medical conditions or comorbidities influencing first-line therapy in unresectable hepatocellular carcinoma in the United States.
Tammy A Schuler ... Bruce Feinberg
Future oncology (London, England) | VOL. -
Tammy A Schuler, et. al.Tammy A Schuler ... Bruce Feinberg
15 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.